Chairman of the Board

Mr. Mackie is Chairman of bioLytical™ Laboratories Inc. His career in business spans more than 20 years; providing leadership and expertise to a number of companies. Mr. Mackie is experienced in import/export, business-to-business transactions, corporate takeover and restructuring, and marketing strategy. He was co-founder and owner of one of the largest mobile communications companies in Western Canada. For more than 10 years he has successfully managed land and commercial real estate within an international portfolio. Born and raised in British Columbia, Mr. Mackie is actively involved in a number of charitable organizations as well as fund raising for community sports and youth educational programs. He is an active contributor to the INSTI™ Foundation both at home and abroad.

President and Chief Executive Officer

Mr. Roy has almost 25 years of health care leadership experience, across three Canadian provinces and was recently named one of the top 50 most powerful business executives in Vancouver. He was recognized for his ability to develop and execute a vision for facility redevelopment, substantially derived from quality relationships.

Formerly the President and CEO of Providence Health Care (PHC), Mr. Roy has a comprehensive knowledge of health care systems and the devastating impact of HIV/AIDS. PHC, with 6,000 employees and an annual budget of over $500 million, is a preeminent teaching and research health care organization, operating seven facilities in Vancouver. The BC Centre for Excellence in HIV/AIDS, part of Providence’s specialty programming, is Canada's largest HIV/AIDS research and treatment program.

Mr. Roy comes to bioLytical™ Laboratories from Perceptronix Medical Inc. (‘Perceptronix’) where he served as President and Chief Executive Officer from September 2006. Under Mr. Roy’s leadership, Perceptronix successfully shifted its strategic focus from research and development to product commercialization.

Mr. Roy was previously President of Caritas Health Group in Edmonton, Alberta, operating four facilities in collaboration with the Capital Health Authority, a fully integrated academic health sciences centre. Prior to joining Caritas, he was President and Chief Executive Officer of Sudbury General Hospital and St. Joseph's Health Centre in Sudbury, Ontario.

Mr. Roy has a Master of Health Science Administration from the University of Toronto and is a Certified Health Executive (Canadian College of Health Service Executives).

Chief Science Officer

Dr. O’Shaughnessy was hired as founding director of the B.C. Centre for Excellence in HIV/AIDS in 1992. In 2001, he was appointed Vice President of Research and Tertiary Programs at Providence Health Care, and Assistant Dean of Research in the Faculty of Medicine at the University of British Columbia. Under his leadership, the Centre has developed into a national and world leader in HIV/AIDS treatment and research. Dr. O’Shaughnessy retired as Director of the Centre in October 2003, but continues to be an opinion leader in HIV and health care issues.

Chief Technical Officer

Mr. Galli has over 31 years experience in Canada coordinating diagnostic and research laboratories in the area of infectious diseases. He has been directly involved with the laboratory diagnosis and monitoring of HIV infection since 1987, and has served on numerous advisory boards and associations, most recently as president of the Canadian Association of HIV Clinical Laboratory Specialists. Mr. Galli is responsible for bioLytical™’s scientific, clinical and regulatory affairs.

Chief Financial Officer

Mr. Bjornson is the CFO of bioLytical™ Laboratories Inc. In 1994 he received a Bachelor of Commerce (with distinction) from the University of Victoria, British Columbia. In 1995 he commenced his articles with Deloitte Touche Tohmatsu International where he was a member of the assurance and advisory services group working with clients ranging from retail industry to biotechnology. In 1998, he was admitted as a member of the Institute of Chartered Accountants of British Columbia and the Canadian Institute of Chartered Accountants. Prior to joining bioLytical™, Mr. Bjornson was Vice President of a Bermuda group of companies specializing in financial and risk management services. His experience is both international and diverse. All enquiries about bioLytical™’s investor relations or company structure can be forwarded to Mr. Bjornson using our contact form.

Director of Business Development

Mr. Jauhar has over 14 years of entrepreneur experience in various fields including aviation, defence, travel and hospitality, technology acquisition, construction and real estate. Mr. Jauhar was the CEO of Realms, a travel and hospitality company based in New Delhi, India and the CEO of Ace Indo Canada which is involved in marketing and distributing emerging Canadian technologies. Prior to joining bioLytical™, he was the CEO of Realms Trading Inc., a company based in Vancouver providing consultancy services to North American companies in the field of market research, creation of distribution network, technology aquisation and marketing their products for exports. All distributorship and sales enquiries can be sent to Mr.Jauhar at bjauhar@biolytical.com

Director of QA & QC

Mrs. Massey has 9 years of experience in commercial manufacturing and production. She has further experience in certification and management of both ISO 9001 and ISO 13485 certified laboratories. Mrs. Massey received a BSc. in Chemical Engineering from the University of the City of Manila in 1989. Her responsibilities include all aspects of operational production and quality control and assurance.

Director of Manufacturing

Mr. Lozada completed his Bachelor of Science at the University of Santo Tomas in Manila. He has over 20 years experience in development of formulations, equipment qualification and manufacturing process validation, production, quality assurance, and supply chain logistics in the Pharmaceutical and Natural Health Products industry. His diverse experience and scientific background contribute to ensuring compliance of manufacturing equipment and facilities with regulatory requirements of Health Canada, ISO, CE and USFDA, maximizing manufacturing efficiencies, and ensuring cost effective production process and supply chain logistics.

back to top